Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome

JAMA. 2022 Apr 26;327(16):1613-1614. doi: 10.1001/jama.2022.2926.
No abstract available

Publication types

  • Comment

MeSH terms

  • Bronchopulmonary Dysplasia* / complications
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Pulmonary Surfactants* / therapeutic use
  • Respiratory Distress Syndrome, Newborn* / drug therapy
  • Respiratory Distress Syndrome, Newborn* / etiology
  • Respiratory Distress Syndrome, Newborn* / mortality

Substances

  • Pulmonary Surfactants